N Ida

1.8k total citations · 1 hit paper
27 papers, 1.5k citations indexed

About

N Ida is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, N Ida has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in N Ida's work include Cytokine Signaling Pathways and Interactions (7 papers), interferon and immune responses (3 papers) and Immune Response and Inflammation (3 papers). N Ida is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), interferon and immune responses (3 papers) and Immune Response and Inflammation (3 papers). N Ida collaborates with scholars based in Japan, United States and Germany. N Ida's co-authors include Hiromi Oda, Erwin F. Wagner, Sunhwa Kim, Hiroshi Takayanagi, Tomohiko Suzuki, Hiroshi Suzuki, Kozo Nakamura, Koichi Matsuo, Tadatsugu Taniguchi and Taeko Yokochi and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

N Ida

27 papers receiving 1.4k citations

Hit Papers

RANKL maintains bone homeostasis through c-Fos-dependent ... 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Ida Japan 15 700 561 446 326 172 27 1.5k
Muneharu Maruyama Japan 20 561 0.8× 280 0.5× 258 0.6× 194 0.6× 145 0.8× 61 1.3k
Takeshi Kasajima Japan 20 601 0.9× 266 0.5× 369 0.8× 184 0.6× 160 0.9× 69 1.6k
William L. Ries United States 20 895 1.3× 430 0.8× 420 0.9× 173 0.5× 111 0.6× 42 1.5k
Eleni Mylona Greece 20 692 1.0× 364 0.6× 157 0.4× 175 0.5× 180 1.0× 43 1.4k
Katsumi Eguchi Japan 19 1.1k 1.5× 406 0.7× 336 0.8× 89 0.3× 246 1.4× 38 1.7k
Masayuki Tsuchiya Japan 20 712 1.0× 418 0.7× 721 1.6× 210 0.6× 123 0.7× 41 2.1k
H. Kurachi Japan 26 491 0.7× 352 0.6× 214 0.5× 173 0.5× 126 0.7× 56 1.7k
Muriel Gaudry France 25 909 1.3× 219 0.4× 741 1.7× 307 0.9× 135 0.8× 36 1.9k
E Abe Japan 14 576 0.8× 335 0.6× 242 0.5× 76 0.2× 97 0.6× 20 1.2k
Hirofumi Koga Japan 24 569 0.8× 379 0.7× 302 0.7× 190 0.6× 133 0.8× 85 2.1k

Countries citing papers authored by N Ida

Since Specialization
Citations

This map shows the geographic impact of N Ida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Ida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Ida more than expected).

Fields of papers citing papers by N Ida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Ida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Ida. The network helps show where N Ida may publish in the future.

Co-authorship network of co-authors of N Ida

This figure shows the co-authorship network connecting the top 25 collaborators of N Ida. A scholar is included among the top collaborators of N Ida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Ida. N Ida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ida, N, et al.. (2024). Effect of Cnidoscolus aconitifolius Leaf Extract in Lowering Triglyceride Levels and Body Weight of Wistar Rats with Metabolic Syndrome. SHILAP Revista de lepidopterología. 11(3). 164–171. 1 indexed citations
2.
Ida, N, et al.. (2011). Safety Assessment of a Prostacyclin Derivative (Beraprost Sodium) in Healthy Cats. 20(4). 131–139. 3 indexed citations
3.
Machida, Noboru, et al.. (2009). Effect of beraprost sodium (BPS) in a new rat partial unilateral ureteral obstruction model. Prostaglandins Leukotrienes and Essential Fatty Acids. 80(5-6). 263–267. 10 indexed citations
4.
Takayanagi, Hiroshi, Sunhwa Kim, Koichi Matsuo, et al.. (2002). RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature. 416(6882). 744–749. 574 indexed citations breakdown →
5.
Anthony, Karen, Stefan Dübel, N Ida, et al.. (1998). Epitopes fused to F-pilin are incorporated into functional recombinant pili. Journal of Molecular Biology. 279(3). 589–603. 11 indexed citations
6.
Schröder, J., Johannes Pantel, N Ida, et al.. (1997). Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging. Molecular Psychiatry. 2(6). 505–507. 42 indexed citations
7.
Alam, Rafeul, J York, Michael Boyars, et al.. (1996). Increased MCP-1, RANTES, and MIP-1alpha in Bronchoalveolar Lavage Fluid of Allergic Asthmatic Patients. American Journal of Respiratory and Critical Care Medicine. 153(4). 1398–1404. 258 indexed citations
8.
Naruto, Masanobu, et al.. (1996). Injection Time of Interleukin-6 Determines Fatal Outcome in Experimental Endotoxin Shock. Journal of Interferon & Cytokine Research. 16(12). 995–1000. 32 indexed citations
9.
Izawa, Akiko, et al.. (1994). Effects of natural human interleukin-6 on thrombopoiesis and tumor progression in tumor-bearing mice. Cancer Letters. 79(1). 83–89. 7 indexed citations
10.
Rock, Fernando, Xiaomao Li, Pele Chong, N Ida, & Michel Klein. (1994). Roles of Disulfide Bonds in Recombinant Human Interleukin 6 Conformation. Biochemistry. 33(17). 5146–5154. 27 indexed citations
11.
May, L T, et al.. (1992). High levels of “complexed” interleukin-6 in human blood.. Journal of Biological Chemistry. 267(27). 19698–19704. 109 indexed citations
12.
Kakumu, Shinichi, T Shinagawa, T Ishikawa, et al.. (1991). Serum interleukin 6 levels in patients with chronic hepatitis B.. PubMed. 86(12). 1804–8. 46 indexed citations
13.
Higashi, Yasuyuki, N Ida, & Masanobu Tokushige. (1988). Fumaraldehydic acid-induced inactivation of aspartase.. PubMed. 17(1). 103–9. 2 indexed citations
14.
Kakiuchi, Kiyomi, Yuji Katō, Yoshito Tobe, et al.. (1987). Antiproliferating polyquinanes. V Di- and triquinanes involving .ALPHA.-methylene or .ALPHA.-alkylidene cyclopentanone, cyclopentanone, and .GAMMA.-lactone systems.. Chemical and Pharmaceutical Bulletin. 35(2). 617–631. 14 indexed citations
15.
Ida, N & Masanobu Tokushige. (1985). Assignment of ozone-sensitive tryptophan residue in tryptophanase by a dual-monitoring high-performance liquid chromatography system.. PubMed. 7(1). 38–42. 5 indexed citations
16.
Shimizu, Hirohiko M., et al.. (1984). Different Pharmacokinetics Between Natural and Recombinant Human Interferon Beta in Rabbits. Journal of Interferon Research. 4(3). 411–422. 20 indexed citations
17.
Ida, N, et al.. (1982). Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice.. PubMed. 73(6). 952–60. 19 indexed citations
18.
Ida, N, et al.. (1982). Effects of human fibroblast interferon on human tumors transplanted into nude mice: sensitivity of human tumors to interferon.. PubMed. 73(6). 945–51. 14 indexed citations
19.
Kataoka, Tateshi, Fujiko Oh-hashi, Yoshio Sakurai, & N Ida. (1982). Characteristics of in vitro antiproliferation activity of human interferon-?. Cancer Chemotherapy and Pharmacology. 9(2). 75–80. 19 indexed citations
20.
Kataoka, Tateshi, Yoshio Sakurai, N Ida, & Shigeyasu Kobayashi. (1980). Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan. Cancer Treatment Reviews. 7(4). 253–256. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026